Hifibio Therapeutics
Clinical trials sponsored by Hifibio Therapeutics, explained in plain language.
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control OngoingThis study tests an experimental drug called HFB200603, alone or with another immunotherapy (tislelizumab), in adults with advanced solid tumors like kidney, lung, skin, stomach, or colorectal cancer. The goal is to find a safe dose and see how well the body tolerates it. About 8…
Phase: PHASE1 • Sponsor: HiFiBiO Therapeutics • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
New drug combo targets Hard-to-Treat cancers in early trial
Disease control OngoingThis study tests an experimental drug called HFB200301, alone or with another drug (tislelizumab), in adults with advanced solid tumors like stomach, kidney, or lung cancer. The main goal is to find safe doses and check for side effects. About 72 people will take part, and the st…
Phase: PHASE1 • Sponsor: HiFiBiO Therapeutics • Aim: Disease control
Last updated May 04, 2026 16:31 UTC